» Articles » PMID: 15128858

Transient Receptor Potential Vanilloid 4 is Essential in Chemotherapy-induced Neuropathic Pain in the Rat

Overview
Journal J Neurosci
Specialty Neurology
Date 2004 May 7
PMID 15128858
Citations 140
Authors
Affiliations
Soon will be listed here.
Abstract

The development of treatments for neuropathic pain has been hindered by our limited understanding of the basic mechanisms underlying abnormalities in nociceptor hyperexcitability. We recently showed that the polymodal receptor transient receptor potential vanilloid 4 (TRPV4), a member of the transient receptor potential (TRP) family of ion channels, may play a role in inflammatory pain (Alessandri-Haber et al., 2003). The present study tested whether TRVP4 also contributes to neuropathic pain, using a rat model of Taxol-induced painful peripheral neuropathy. Taxol is the most widely used drug for the treatment of a variety of tumor types, but the dose of Taxol that can be tolerated is limited by the development of a small-fiber painful peripheral neuropathy. We found that Taxol treatment enhanced the nociceptive behavioral responses to both mechanical and hypotonic stimulation of the hind paw. Spinal administration of antisense oligodeoxynucleotides to TRPV4, which reduced the expression of TRPV4 in sensory nerve, abolished Taxol-induced mechanical hyperalgesia and attenuated hypotonic hyperalgesia by 42%. The enhancement of osmotic nociception involves sensitization of osmotransduction in primary afferents because osmotransduction was enhanced in cultured sensory neurons isolated from Taxol-treated rats. Taxol-induced TRPV4-mediated hyperalgesia and the enhanced osmotransduction in cultured nociceptors were dependent on integrin/Src tyrosine kinase signaling. These results suggest that TRPV4 plays a crucial role in a painful peripheral neuropathy, making it a very promising target for the development of a novel class of analgesics.

Citing Articles

Research progress of TRPV4 in pain over the past 20 years: a bibliometric analysis.

Huang L, Xuan Q, Li Y, Huang J, Fang F Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39951114 DOI: 10.1007/s00210-025-03846-0.


G-protein-coupled estrogen receptor 30 regulation of signaling downstream of protein kinase Cε mediates sex dimorphism in hyaluronan-induced antihyperalgesia.

Bonet I, Araldi D, Khomula E, Bogen O, Green P, Levine J Pain. 2025; 166(3):539-556.

PMID: 39787533 PMC: 11810595. DOI: 10.1097/j.pain.0000000000003419.


The Nociceptor Primary Cilium Contributes to Mechanical Nociceptive Threshold and Inflammatory and Neuropathic Pain.

Fitzsimons L, Staurengo-Ferrari L, Khomula E, Bogen O, Araldi D, Bonet I J Neurosci. 2024; 44(47).

PMID: 39349056 PMC: 11580782. DOI: 10.1523/JNEUROSCI.1265-24.2024.


Regulation of Neural Functions by Brain Temperature and Thermo-TRP Channels.

Shibasaki K Adv Exp Med Biol. 2024; 1461:199-211.

PMID: 39289283 DOI: 10.1007/978-981-97-4584-5_14.


Targeting TRPV4 Channels for Cancer Pain Relief.

Antoniazzi C, Andrighetto Ruviaro N, Peres D, Rodrigues P, Viero F, Trevisan G Cancers (Basel). 2024; 16(9).

PMID: 38730655 PMC: 11083562. DOI: 10.3390/cancers16091703.


References
1.
Walker R, Willingham A, Zuker C . A Drosophila mechanosensory transduction channel. Science. 2000; 287(5461):2229-34. DOI: 10.1126/science.287.5461.2229. View

2.
Caterina M, Leffler A, Malmberg A, Martin W, Trafton J, Koltzenburg M . Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000; 288(5464):306-13. DOI: 10.1126/science.288.5464.306. View

3.
Davis J, Gray J, Gunthorpe M, Hatcher J, Davey P, Overend P . Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 2000; 405(6783):183-7. DOI: 10.1038/35012076. View

4.
Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant T . OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol. 2000; 2(10):695-702. DOI: 10.1038/35036318. View

5.
Liedtke W, Choe Y, Bell A, Denis C, Sali A, Hudspeth A . Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell. 2000; 103(3):525-35. PMC: 2211528. DOI: 10.1016/s0092-8674(00)00143-4. View